Strs Ohio Acquires Shares of 37,000 Humana Inc. $HUM

Key Points

• Strs Ohio invested approximately $9.79 million in Humana Inc. by acquiring 37,000 shares of the insurance provider during the first quarter.
• Humana's current market cap is $33.24 billion, and the stock has seen a price fluctuation with a 12-month low of $206.87 and a high of $325.75.
• The company recently declared a quarterly dividend of $0.885 per share, with an annualized yield of 1.3%.

Strs Ohio purchased a new position in shares of Humana Inc. (NYSE:HUM - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 37,000 shares of the insurance provider's stock, valued at approximately $9,790,000.

A number of other large investors have also added to or reduced their stakes in the business. Cary Street Partners Investment Advisory LLC grew its holdings in Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock worth $31,000 after acquiring an additional 46 shares during the last quarter. Riverview Trust Co acquired a new position in shares of Humana during the first quarter worth $34,000. Garde Capital Inc. bought a new stake in shares of Humana in the first quarter worth $36,000. Zions Bancorporation National Association UT acquired a new stake in Humana in the first quarter valued at $37,000. Finally, Whipplewood Advisors LLC raised its position in Humana by 639.1% during the 1st quarter. Whipplewood Advisors LLC now owns 170 shares of the insurance provider's stock worth $45,000 after purchasing an additional 147 shares during the last quarter. Institutional investors own 92.38% of the company's stock.

Humana Stock Down 0.6%

Shares of NYSE:HUM traded down $1.70 during midday trading on Monday, hitting $274.75. 1,271,657 shares of the company's stock were exchanged, compared to its average volume of 1,618,744. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $324.38. The company has a market cap of $33.04 billion, a PE ratio of 21.09, a price-to-earnings-growth ratio of 1.62 and a beta of 0.44. The stock has a 50 day moving average price of $266.10 and a 200-day moving average price of $257.19.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The company had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. Humana's revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter last year, the firm posted $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. On average, sell-side analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, September 26th. This represents a $3.54 annualized dividend and a yield of 1.3%. Humana's dividend payout ratio is 27.17%.

Wall Street Analysts Forecast Growth

A number of research firms have commented on HUM. Barclays upped their price target on Humana from $275.00 to $315.00 and gave the company an "equal weight" rating in a research report on Friday, September 5th. Piper Sandler cut their price objective on Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a research note on Thursday, July 31st. Truist Financial decreased their target price on shares of Humana from $280.00 to $260.00 and set a "hold" rating for the company in a research report on Wednesday, July 16th. Royal Bank Of Canada boosted their price target on shares of Humana from $283.00 to $322.00 and gave the stock an "outperform" rating in a research report on Thursday, August 21st. Finally, Morgan Stanley decreased their price objective on shares of Humana from $290.00 to $277.00 and set an "equal weight" rating for the company in a research report on Thursday, July 31st. Seven investment analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $289.24.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.